Evidence map›Paper›PMID 33251127›Full record

ArticleFrontiers in oncology2020

Multi-Omics Analysis to Characterize Cigarette Smoke Induced Molecular Alterations in Esophageal Cells.

Aafaque Ahmad Khan, Krishna Patel, Shankargouda Patil, Niraj Babu, Kiran K Mangalaparthi, Hitendra Singh Solanki, Vishalakshi Nanjappa, Anjali Kumari, Malini Manoharan, Coral Karunakaran and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 6 countries.

Aafaque Ahmad KhanInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Krishna PatelInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Shankargouda PatilDivision of Oral Pathology, Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Niraj BabuInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Kiran K MangalaparthiInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Hitendra Singh SolankiInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Vishalakshi NanjappaInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Anjali KumariMedgenome Labs Pvt. Ltd., Bangalore, India.
Malini ManoharanMedgenome Labs Pvt. Ltd., Bangalore, India.
Coral KarunakaranMedgenome Labs Pvt. Ltd., Bangalore, India.
Saktivel MuruganMedgenome Labs Pvt. Ltd., Bangalore, India.
Bipin NairAmrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam, India.
Rekha V KumarDepartment of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.
Manjusha BiswasDepartment of Molecular Pathology, Mitra Biotech, Bangalore, India.
David SidranskyDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Ravi GuptaMedgenome Labs Pvt. Ltd., Bangalore, India.
Rohit GuptaMedgenome Labs Pvt. Ltd., Bangalore, India.
Arati Khanna-GuptaMedgenome Labs Pvt. Ltd., Bangalore, India.
Prashant KumarInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Aditi ChatterjeeInstitute of Bioinformatics, International Technology Park, Bangalore, India.
Harsha GowdaInstitute of Bioinformatics, International Technology Park, Bangalore, India.
SciGenom Labs (India) · INInstitute of Bioinformatics · INAmrita Vishwa Vidyapeetham · INHospital for Sick Children · CAJohns Hopkins University · USKidwai Memorial Institute of Oncology · INManipal Academy of Higher Education · INMitra Biotech (India) · INUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Though smoking remains one of the established risk factors of esophageal squamous cell carcinoma, there is limited data on molecular alterations associated with cigarette smoke exposure in esophageal cells. To investigate molecular alterations associated with chronic exposure to cigarette smoke, non-neoplastic human esophageal epithelial cells were treated with cigarette smoke condensate (CSC) for up to 8 months. Chronic treatment with CSC increased cell proliferation and invasive ability of non-neoplastic esophageal cells. Whole exome sequence analysis of CSC treated cells revealed several mutations and copy number variations. This included loss of high mobility group nucleosomal binding domain 2 (HMGN2) and a missense variant in mediator complex subunit 1 (MED1). Both these genes play an important role in DNA repair. Global proteomic and phosphoproteomic profiling of CSC treated cells lead to the identification of 38 differentially expressed and 171 differentially phosphorylated proteins. Bioinformatics analysis of differentially expressed proteins and phosphoproteins revealed that most of these proteins are associated with DNA damage response pathway. Proteomics data revealed decreased expression of HMGN2 and hypophosphorylation of MED1. Exogenous expression of HMGN2 and MED1 lead to decreased proliferative and invasive ability of smoke exposed cells. Immunohistochemical labeling of HMGN2 in primary ESCC tumor tissue sections (from smokers) showed no detectable expression while strong to moderate staining of HMGN2 was observed in normal esophageal tissues. Our data suggests that cigarette smoke perturbs expression of proteins associated with DNA damage response pathways which might play a vital role in development of ESCC.

Indexed as

cigarette smokeDNA repairesophageal squamous cell carcinomamass spectrometrynext generation sequencingtandem mass tag

Identifiers

PMID33251127
PMCPMC7675040
OpenAlexW3095568325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.